Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers

Di Yin(Capital Medical University), Yujia Cai(Shanghai Jiao Tong University), Hang Yang(Wuhan Institute of Virology), Zhijue Xu(Shanghai Ninth People's Hospital), Ruijiao Dong(Shanghai Jiao Tong University), Sikai Ling(Shanghai Jiao Tong University), Sheng‐ce Tao(Shanghai Jiao Tong University), Xiaolong Tian(Fudan University), Jiaxu Hong(Eye & ENT Hospital of Fudan University), Quanjun Wang(National Institutes of Pharmaceutical Research and Development (China)), Ziying Li(Shanghai Jiao Tong University), He‐wei Jiang(Shanghai Jiao Tong University), Wei Hong(Guiyang Medical University), Tianlei Ying(Shanghai Medical College of Fudan University), Yi Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin‐Tai Da(Shanghai Jiao Tong University), Yiye Zhong(Shanghai Jiao Tong University), Xiaoyuan Wang(Regend Therapeutics (China)), Yang Li(Shanghai Jiao Tong University), Yan Zhang(Southwest Minzu University), Xingbo Wang(Regend Therapeutics (China)), Ze‐Guang Han(Shanghai Jiao Tong University), Sicong Lu(Shanghai Jiao Tong University), Yuqing Wu(University of Duisburg-Essen), Yao Dai(Shanghai Jiao Tong University), Junsong Chen(Shanghai Jiao Tong University), Zhuofan Jiang(Shanghai Jiao Tong University), Jian-jiang Xu(Eye & ENT Hospital of Fudan University), Jie Wang(Shanghai Jiao Tong University), Heng Xue(Chinese Academy of Sciences), Qijing Huang(Shanghai Jiao Tong University)
Nature Biomedical Engineering
May 7, 2024
Cited by 89


Related Papers